Janus Henderson Investors US’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$58.7M Sell
1,981,838
-1,282,231
-39% -$35M 0.05% 407
2016
Q4
$81M Sell
3,264,069
-596,492
-15% -$13.6M 0.07% 346
2016
Q3
$87.1M Buy
3,860,561
+19,204
+0.5% +$451K 0.07% 327
2016
Q2
$91.5M Buy
3,841,357
+1,419,863
+59% +$34.1M 0.08% 306
2016
Q1
$57.5M Buy
2,421,494
+1,403,138
+138% +$34.3M 0.05% 400
2015
Q4
$28.3M Buy
+1,018,356
New +$25.6M 0.02% 548

Other funds holding GMED

Janus Henderson Investors US's GMED Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Globus Medical (GMED) stake by 39% in Q1 2017, selling an estimated $35M and leaving 1,981,838 shares worth $58.7M. The position accounts for 0.05% of the portfolio, ranked #407.

Janus Henderson Investors US first reported a position in GMED in Q4 2015 and has held it in 6 quarters since. The position peaked at $91.5M in Q2 2016. 243 funds tracked by Wall St. Rank hold GMED as of Q1 2017.

  • Janus Henderson Investors US held 1,981,838 shares of Globus Medical worth $58.7M as of Q1 2017.
  • Janus Henderson Investors US sold 1,282,231 Globus Medical shares in Q1 2017, an estimated $35M.
  • Globus Medical made up 0.05% of Janus Henderson Investors US's portfolio in Q1 2017, its #407 holding.
  • Janus Henderson Investors US first reported a position in Globus Medical in Q4 2015 and has held it in 6 quarters since.
  • Janus Henderson Investors US's Globus Medical position peaked at $91.5M in Q2 2016.
  • 243 funds tracked by Wall St. Rank held Globus Medical as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.